One of the six WHO Regions, WHO South-East Asia is home to over a quarter of the world’s population.
Committed to building a better, healthier future for the nearly two billion people in the Region, WHO is working with the 11 Member States to address persisting and emerging epidemiological and demographic challenges.
UN agencies warn economic impact of COVID-19 and worsening inequalities will fuel malnutrition for billions in Asia and the Pacific - Child and maternal diets particularly vulnerable
Marking a decade since last polio case: WHO SEAR countries gear up for massive vaccination campaign – this time for COVID-19 virus
Featured activitiesAll →
Noncommunicable diseases are the no. 1 killers in the WHO SEA Region
Noncommunicable diseases (NCDs) — mainly cardiovascular diseases, chronic respiratory diseases, diabetes and cancer — are top killers in the South-East Asia Region, cla ...
The fatal link between tobacco and cardiovascular diseases in the WHO South-East Asia Region, May 2018
The most common way by which tobacco kills is by causing CVDs, including heart disease and stroke. The good news is that quitting tobacco use at any age reduces the risk of CVDs im ...
Several medical conditions like diabetes, malnutrition, HIV, tobacco-smoking and alcohol-use are risk factors for TB and for poor TB treatment results. Therefore, it is important t ...
The Asia Pacific Observatory on Health Systems and Policies (the APO) is a collaborative partnership of interested governments, international agencies, foundations, and researchers that promotes evidence-informed health systems policy regionally and in all countries in the Asia Pacific region.
The Global Leprosy Programme (GLP) of the World Health Organization is housed in the WHO Regional Office for South-East Asia (and not in the Organization’s headquarters in Geneva). It is the Organization’s designated programme for addressing leprosy worldwide. Being classified as one of the 20 neglected tropical diseases (NTDs), the unit works in close collaboration with the Department of Control of NTDs in HQ, designated focal points in all regions, national leprosy programmes and partners.